Cantor Fitzgerald Starts Hutchison China MediTech Ltd. (HCM) at Overweight
- Wall Street closes rollercoaster week sharply lower
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- FDA Votes "No" on Pfizer (PFE) Booster for 16+ Age Group, 2 Yes 16 No
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Cantor Fitzgerald initiates coverage on Hutchison China MediTech Ltd. (NASDAQ: HCM) with a Overweight rating.
Shares of Hutchison China MediTech Ltd. closed at $23.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Recordati SpA (REC:IM) (RCDTF) at Equalweight
- Nomura/Instinet Starts Siemens Ltd. (SIEM:IN) at Neutral
- Credit Suisse Starts Delta Electronics Thailand PCL (DELTA:TB) at Underperform
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesCantor Fitzgerald
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!